New pill for postpartum depression a vital breakthrough

New pill for postpartum depression a vital breakthrough
One in seven new mothers develop the serious medical condition. (Image: Getty)
Bloomberg
By Lisa Jarvis The landmark approval in the US of the first pill for postpartum depression offers an important new treatment for the 1 in 7 new mothers who develop the condition. Suicide is a leading cause of maternal mortality in the US. And yet on its own, the new drug – promising as it is – isn’t enough. Consider that as many as half of women with postpartum depression go undiagnosed.Nonetheless, the new pill is a remarkable breakthrough, and one of several encouraging recent developments in women’s health &...

More Health

Ebos targets pharmacy revenue growth
Markets

Ebos targets pharmacy revenue growth

The dual-listed company cracked revenue of A$13b for the first time in 2024.

Staff reporters 23 Oct 2024
ACC books plunge $7.2b into deficit
Economy

ACC books plunge $7.2b into deficit

The Accident Compensation Corporation concedes there’s room for it to tighten its processes, as it proposes increasing the levies it charges to help pay for rising claims costs.However, the state insurer warns the constrained health system is hampering efforts to get injured peop...

Staff reporters 16 Oct 2024
Why Dunedin Hospital's costs blew out
Finance

Why Dunedin Hospital's costs blew out

Vital's Aaron Hockly says the bigger the project, the harder it is to control.

Dileepa Fonseka 10 Oct 2024
Luxon aims to extend private sector's role in healthcare
Politics

Luxon aims to extend private sector's role in healthcare

The PM wants to make it easier for the public health system to outsource some of its work.

Dileepa Fonseka 08 Oct 2024